CRISPR/Cas-mediated DNA base editing technology and its application in biomedicine and agriculture.
- Author:
Chuanzhao YU
1
;
Jianxin MO
2
;
Xin ZHAO
1
;
Guoling LI
1
;
Xianwei ZHANG
2
Author Information
- Publication Type:Review
- Keywords: CRISPR/Cas; adenine base editors; base editing; cytidine base editors; prime editors
- MeSH: Agriculture; CRISPR-Cas Systems/genetics*; DNA/genetics*; Gene Editing; Technology
- From: Chinese Journal of Biotechnology 2021;37(9):3071-3087
- CountryChina
- Language:Chinese
- Abstract: In recent years, the genome editing technologies based on the clustered regularly interspaced short palindromic repeats/CRISPR-associated protein (CRISPR/Cas) have developed rapidly. The system can use homologous directed recombination (HDR) to achieve precise editing that it medicated, but the efficiency is extremely low, which limits its application in agriculture and biomedical fields. As an emerging genome editing technology, the CRISPR/Cas-mediated DNA base editing technologies can achieve targeted mutations of bases without generating double-strand breaks, and has higher editing efficiency and specificity compared with CRISPR/Cas-mediated HDR editing. At present, cytidine base editors (CBEs) that can mutate C to T, adenine base editors (ABEs) that can mutate A to G, and prime editors (PEs) that enable arbitrary base conversion and precise insertion and deletion of small fragments, have been developed. In addition, glycosylase base editors (GBEs) capable of transitioning from C to G and double base editors capable of editing both A and C simultaneously, have been developed. This review summarizes the development, advances, advantages and limitations of several DNA base editors. The successful applications of DNA base editing technology in biomedicine and agriculture, together with the prospects for further optimization and selection of DNA base editors, are discussed.
